GSK3B and Alzheimer disease: These 14-3-3 isoforms can also bind to GSK-3β [14,40], which is increased in AD and MetS [98,124], with the simultaneous binding to tau and GSK-3β promoting tau phosphorylation, which can eventually lead to the formation of NFTs [125].